Navina, founded in 2018 and headquartered in Tel Aviv, was built to solve a problem that sits at the heart of value-based care: clinicians are drowning in fragmented data but starved of usable insight. A typical patient's record is scattered across claims, labs, prior notes, and external documents, and no physician has time to reconstruct the full picture during a short visit. Navina's AI engine ingests that fragmented data and synthesizes it into a clear, prioritized summary, then layers on recommendations that appear at the point of care.
The company's copilot is particularly tuned for value-based care, where reimbursement depends on accurately capturing patient complexity, closing care gaps, and documenting conditions properly. Navina surfaces suspected and undocumented diagnoses, flags overdue screenings and preventive care, and helps clinicians and coders ensure that the work they do is reflected in the record. For organizations bearing financial risk, this combination of better care and more complete documentation translates directly into both clinical quality and revenue.
Navina's $55M Series C, announced in March 2025, was led by Growth Equity at Goldman Sachs Alternatives, with existing investors Vertex Ventures Israel, Grove Ventures, and ALIVE participating. The round brought total funding to $100M and was earmarked for accelerating U.S. market expansion and deepening the company's proprietary AI. By that point Navina's copilot was serving more than 10,000 healthcare professionals across roughly 1,300 clinics and supporting care for over three million patients, with adoption by leading value-based care organizations such as Privia Health, agilon health, and Millennium Physician Group.
Navina's customers are primary care groups and value-based care organizations that need to manage population complexity at scale. Its strategic position rests on being an at-the-point-of-care intelligence layer that integrates into existing workflows rather than asking clinicians to learn a new system. As value-based care continues to expand across U.S. healthcare, the demand for tools that turn raw data into proactive, in-visit clinical intelligence grows with it, and Navina's deployed base and enterprise partnerships give it real momentum in that market.